ENDOD1 Inhibitors
ENDOD1 inhibitors are a class of chemical compounds that target the enzyme Endonuclease Domain-Containing 1 (ENDOD1). ENDOD1 is a relatively less characterized enzyme but is believed to play a role in the regulation of nucleic acids, particularly in cleaving specific sequences within RNA and DNA. Inhibitors of ENDOD1 are designed to selectively bind to the enzyme and disrupt its catalytic activity, which typically involves breaking phosphodiester bonds within nucleic acid molecules. The exact mechanism of inhibition varies depending on the structure of the inhibitor, but most function by either competing with the natural substrate for the active site of ENDOD1 or by inducing conformational changes that render the enzyme inactive. These inhibitors often exhibit a high degree of specificity due to the unique active site configuration of ENDOD1.
The design of ENDOD1 inhibitors is heavily influenced by structural studies of the enzyme, such as X-ray crystallography or cryo-electron microscopy, which provide insights into the enzyme's three-dimensional shape and binding sites. Structure-activity relationship (SAR) analysis is frequently employed to fine-tune the binding affinity and selectivity of these inhibitors. This involves systematic modifications to the chemical structure of potential inhibitors to identify functional groups that enhance interaction with ENDOD1. Moreover, ENDOD1 inhibitors may differ significantly in terms of their molecular weight, solubility, and binding kinetics, all of which affect their efficiency in interacting with the enzyme. Further biochemical and biophysical studies are often carried out to characterize these inhibitors in terms of their binding constants, inhibitory concentrations, and effects on the enzyme's structural stability.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent protein kinase inhibitor that impedes protein kinase C (PKC) among other kinases. Inhibition of PKC leads to reduced phosphorylation of downstream effectors, potentially impairing processes like endocytosis where ENDOD1 is involved. Reduced phosphorylation can hinder the recruitment of necessary factors for vesicle formation, consequently inhibiting the functional activity of ENDOD1 by limiting its ability to participate in endocytosis. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is an inhibitor of tyrosine kinases which participate in the phosphorylation of key proteins in multiple signaling pathways. By inhibiting these kinases, Genistein can reduce the phosphorylation-dependent recruitment of molecules important for endocytosis, a process that is critical for ENDOD1 activity. As a result, ENDOD1's function is indirectly inhibited due to the disruption of its associated signaling events. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits phosphoinositide 3-kinases (PI3Ks), which are critical for the production of PIP3, a lipid that recruits proteins to initiate endocytosis. Inhibiting PI3K leads to impaired vesicle formation and trafficking, directly impacting ENDOD1's role in endocytosis since its functional activity is closely tied to these processes. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore targets and inhibits the GTPase activity of dynamin, which is crucial for the scission of clathrin-coated vesicles from the plasma membrane during endocytosis. By inhibiting dynamin, Dynasore impedes vesicle release and trafficking, thereby indirectly inhibiting ENDOD1's function in this pathway. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine interferes with clathrin-mediated endocytosis by inhibiting the assembly of clathrin and adaptor proteins on the plasma membrane. This disruption leads to the functional inhibition of ENDOD1, as it cannot perform its role in endocytosis without proper clathrin coat assembly. | ||||||
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $57.00 | 6 | |
Amiloride inhibits Na+/H+ exchangers, which can result in altered endosomal pH and ionic balance, affecting endosome maturation. The functional activity of ENDOD1 in trafficking and processing within endosomes is thus indirectly inhibited by the disruption of endosomal maturation caused by Amiloride. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
Methyl-β-cyclodextrin extracts cholesterol from cell membranes, disrupting lipid rafts and membrane fluidity. Since lipid rafts are involved in certain endocytic pathways, the disruption of these structures can hinder the functionality of ENDOD1 by affecting the formation of endocytic vesicles where ENDOD1 operates. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 inhibits the vacuolar-type H+-ATPase, preventing acidification of endosomes, a necessary step for proper vesicle trafficking and maturation. This inhibition directly affects ENDOD1's activity as it is dependent on these processes for its function in endocytosis. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Pitstop 2 blocks the interaction between clathrin and adaptor proteins by inhibiting the clathrin terminal domain, essential for clathrin-coated pit formation. ENDOD1's function is indirectly inhibited as the formation of endocytic vesicles, a process in which ENDOD1 is involved, is disrupted. | ||||||
Dansylcadaverine | 10121-91-2 | sc-214851 sc-214851A sc-214851B | 100 mg 250 mg 1 g | $52.00 $89.00 $240.00 | 4 | |
Monodansylcadaverine inhibits transglutaminase and impedes clathrin-dependent endocytosis by interfering with the assembly of clathrin-coated pits. Such inhibition disrupts the endocytic pathway where ENDOD1 operates, leading to its functional inhibition. | ||||||